Drug Study Shows No Benefit for Some Covid-19 Patients

Drug Study Shows No Benefit for Some Covid-19 Patients

By The Wall Street Journal

Regeneron Pharmaceuticals and Sanofi halt a study of arthritis therapy Kevzara for certain Covid-19 patients. Supreme Court rules U.S. must pay insurers. Apple delays iPhone production ramp-up. J.R. Whalen reports. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
-
Heart UK
Mute/Un-mute